APA
Davis I. D., Brady B., Kefford R. F., Millward M., Cebon J., Skrumsager B. K., Mouritzen U., Hansen L. T., Skak K., Lundsgaard D., Frederiksen K. S., Kristjansen P. E. G. & McArthur G. (20090416). Clinical and biological efficacy of recombinant human interleukin-21 in patients with stage IV malignant melanoma without prior treatment: a phase IIa trial. : Clinical cancer research : an official journal of the American Association for Cancer Research.
Chicago
Davis Ian D, Brady Ben, Kefford Richard F, Millward Michael, Cebon Jonathan, Skrumsager Birte K, Mouritzen Ulrik, Hansen Lasse Tengbjerg, Skak Kresten, Lundsgaard Dorthe, Frederiksen Klaus Stensgaard, Kristjansen Paul E G and McArthur Grant. 20090416. Clinical and biological efficacy of recombinant human interleukin-21 in patients with stage IV malignant melanoma without prior treatment: a phase IIa trial. : Clinical cancer research : an official journal of the American Association for Cancer Research.
Harvard
Davis I. D., Brady B., Kefford R. F., Millward M., Cebon J., Skrumsager B. K., Mouritzen U., Hansen L. T., Skak K., Lundsgaard D., Frederiksen K. S., Kristjansen P. E. G. and McArthur G. (20090416). Clinical and biological efficacy of recombinant human interleukin-21 in patients with stage IV malignant melanoma without prior treatment: a phase IIa trial. : Clinical cancer research : an official journal of the American Association for Cancer Research.
MLA
Davis Ian D, Brady Ben, Kefford Richard F, Millward Michael, Cebon Jonathan, Skrumsager Birte K, Mouritzen Ulrik, Hansen Lasse Tengbjerg, Skak Kresten, Lundsgaard Dorthe, Frederiksen Klaus Stensgaard, Kristjansen Paul E G and McArthur Grant. Clinical and biological efficacy of recombinant human interleukin-21 in patients with stage IV malignant melanoma without prior treatment: a phase IIa trial. : Clinical cancer research : an official journal of the American Association for Cancer Research. 20090416.